25 results on '"Antimicrobial resistance surveillance"'
Search Results
2. Phenotypic and Genotypic Analysis of Antimicrobial Resistance in Escherichia coli Recovered from Feedlot Beef Cattle in Australia
- Author
-
Yohannes E. Messele, Mauida Alkhallawi, Tania Veltman, Darren J. Trott, Joe P. McMeniman, Stephen P. Kidd, Wai Y. Low, and Kiro R. Petrovski
- Subjects
antimicrobial resistance genes ,antimicrobial resistance surveillance ,cattle feedlot ,cattle slaughterhouse ,multidrug resistance ,General Veterinary ,Animal Science and Zoology - Abstract
This study investigated the antimicrobial resistance (AMR) profile of fecal Escherichia coli isolates from beef cattle (n = 150) at entry and exit from an Australian feedlot. Sample plating on MacConkey agar and Brilliance ESBL agar differentiated generic from extended-spectrum β-lactamase (ESBL)-producing E. coli, respectively. Resistance profiles were determined by minimum inhibitory concentration (MIC) testing and further analyzed by whole-genome sequencing (WGS). At entry, the prevalence of antimicrobial resistance to amoxicillin/clavulanic acid, ampicillin, streptomycin, and trimethoprim/sulfamethoxazole was very low (0.7%, each). At the exit, the resistance prevalence was moderate to tetracycline (17.8%) and low to ampicillin (5.4%), streptomycin (4.7%), and sulfisoxazole (3.9%). The most common AMR genes observed in phenotypically resistant isolates were tet(B) (43.2%), aph(3″)-Ib and aph(6)-Id (32.4%), blaTEM-1B, and sul2 (24.3%, each), which are responsible for resistance to tetracyclines, aminoglycosides, β-lactams, and sulfonamides, respectively. The ESBL-producing E. coli were recovered from one sample (0.7%) obtained at entry and six samples (4.0%) at the exit. The ESBL-producing E. coli harbored blaTEM (29.7%), blaCTX m(13.5%), and blaCMY (5.4%). The resistance phenotypes were highly correlated with resistance genotypes (r ≥ 0.85: p < 0.05). This study demonstrated that E. coli isolated from feedlot beef cattle can harbour AMR genes, but the low incidence of medically important resistance reflected the prudent antimicrobial use in the Australian industry.
- Published
- 2022
3. Population-level faecal metagenomic profiling as a tool to predict antimicrobial resistance in Enterobacterales isolates causing invasive infections: an exploratory study across Cambodia, Kenya, and the UK
- Author
-
Rahul Batra, Sarah Lamble, Ben S. Cooper, Jeremy Swann, Joseph Waichungo, Nicole Stoesser, Derrick W. Crook, Sarah Walker, Hyun S. Gweon, Olga Tosas Auguet, Kevin K Chau, Jonathan D. Edgeworth, Paul Turner, James A. Berkley, Rene Niehus, Tim E. A. Peto, and Tsi Njim
- Subjects
Medicine (General) ,medicine.medical_specialty ,Kenya ,Population ,01 natural sciences ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,Antibiotic resistance ,Environmental health ,Credible interval ,Global health ,Medicine ,030212 general & internal medicine ,0101 mathematics ,education ,education.field_of_study ,business.industry ,Public health ,010102 general mathematics ,General Medicine ,Clinical trial ,Biology and Microbiology ,Clinical infection ,Metagenomics ,Health ,Antimicrobial resistance surveillance ,business ,Research Paper - Abstract
Background Antimicrobial resistance (AMR) in Enterobacterales is a global health threat. Capacity for individual-level surveillance remains limited in many countries, whilst population-level surveillance approaches could inform empiric antibiotic treatment guidelines. Methods In this exploratory study, a novel approach to population-level prediction of AMR in Enterobacterales clinical isolates using metagenomic (Illumina) profiling of pooled DNA extracts from human faecal samples was developed and tested. Taxonomic and AMR gene profiles were used to derive taxonomy-adjusted population-level AMR metrics. Bayesian modelling, and model comparison based on cross-validation, were used to evaluate the capacity of each metric to predict the number of resistant Enterobacterales invasive infections at a population-level, using available bloodstream/cerebrospinal fluid infection data. Findings Population metagenomes comprised samples from 177, 157, and 156 individuals in Kenya, the UK, and Cambodia, respectively, collected between September 2014 and April 2016. Clinical data from independent populations included 910, 3356 and 197 bacterial isolates from blood/cerebrospinal fluid infections in Kenya, the UK and Cambodia, respectively (samples collected between January 2010 and May 2017). Enterobacterales were common colonisers and pathogens, and faecal taxonomic/AMR gene distributions and proportions of antimicrobial-resistant Enterobacterales infections differed by setting. A model including terms reflecting the metagenomic abundance of the commonest clinical Enterobacterales species, and of AMR genes known to either increase the minimum inhibitory concentration (MIC) or confer clinically-relevant resistance, had a higher predictive performance in determining population-level resistance in clinical Enterobacterales isolates compared to models considering only AMR gene information, only taxonomic information, or an intercept-only baseline model (difference in expected log predictive density compared to best model, estimated using leave-one-out cross-validation: intercept-only model = -223 [95% credible interval (CI): -330,-116]; model considering only AMR gene information = -186 [95% CI: -281,-91]; model considering only taxonomic information = -151 [95% CI: -232,-69]). Interpretation Whilst our findings are exploratory and require validation, intermittent metagenomics of pooled samples could represent an effective approach for AMR surveillance and to predict population-level AMR in clinical isolates, complementary to ongoing development of laboratory infrastructures processing individual samples. Funding The study was funded by Bill & Melinda Gates Foundation (grant agreement OPP1160974) and was sponsored by University of Oxford. The study was also supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, and NIHR Health Protection Research Unit in Healthcare-associated Infections and Antimicrobial Resistance (a partnership between the University of Oxford and Public Health England [PHE]). Kenyan samples were collected in a study funded by the MRC/DfID/Wellcome Joint Clinical Trials scheme: MR/M007367/1.
- Published
- 2021
- Full Text
- View/download PDF
4. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
- Author
-
Cantón, Rafael, Loza, Elena, Aznar, Javier, Castillo, Francisco Javier, Cercenado, Emilia, Fraile-Ribot, Pablo Arturo, González-Romo, Fernando, López-Hontangas, José Luis, Rodríguez-Lozano, Jesús, Suárez-Barrenechea, Ana Isabel, Tubau, Fe, Díaz-Regañón, Jazmín, and López-Mendoza, Diego
- Subjects
Adult ,Male ,Original ,intra-abdominal infection ,infección intraabdominal ,Microbial Sensitivity Tests ,beta-Lactamases ,antimicrobial resistance surveillance ,Drug Resistance, Bacterial ,Gram-Negative Bacteria ,polycyclic compounds ,Humans ,Aged ,infección urinaria ,betalactamasas de espectro extendido ,Cross Infection ,Middle Aged ,bacterial infections and mycoses ,Anti-Bacterial Agents ,vigilancia epidemiológica de la resistencia ,Spain ,Population Surveillance ,extended-spectrum-beta-lactamases ,Urinary Tract Infections ,Intraabdominal Infections ,carbapenems ,Female ,urinary tract infection ,Gram-Negative Bacterial Infections - Abstract
Introduction Continuous antimicrobial resistance surveillance is recommended by Public Health authorities. We updated data from the SMART (Study for Monitoring Antimicrobial Resistance Trends) surveillance study in Spain. Material and methods The antimicrobial susceptibility data and extended-spectrum beta-lactamase (ESBL) production in isolates recovered from intra-abdominal (IAI) (n=1,429) and urinary tract (UTI) (n=937) infections during the 2016-2017 SMART study in 10 Spanish hospitals were analysed. Results Escherichia coli was the most frequently microorganism isolated (48.3% and 53.7%) followed by Klebsiella spp. (11.5% and 21.9%) in IAIs and UTIs, respectively. Figures for Pseudomonas aeruginosa were 9.0% and 6.1%, being more frequently recovered from patients with nosocomial infections. Overall, 9.9% (IAI) and 14.0% (UTI) of E. coli, Klebsiella spp. and Proteus mirabilis isolates were ESBL-producers, being Klebsiella pneumoniae (34.5%) from UTI of nosocomial origin the most frequent. ESBL-producers were higher in patients >60 years in both IAIs and UTIs. As in previous years, amikacin (96.3%-100% susceptibility), ertapenem (84.2%-100%) and imipenem (70.3%-100%) were the most active antimicrobials tested among Enterobacterales species. The activity of amoxicillin-clavulanic, piperacillin-tazobactam, and ciprofloxacin susceptibility was lower, particularly among ESBL-producers. Ertapenem susceptibility (88.9%-100%) was retained in ESBL-E. coli isolates that were resistant to these antimicrobials but decreased (28.6%-100%) in similar isolates of K. pneumoniae. Conclusions Continuous antimicrobial resistance surveillance from the SMART study reveals overall maintenance of ESBL-producers in Spain, although with higher presence in isolates from UTIs than from IAIs. Moreover, ertapenem activity was high in E. coli irrespective of ESBL production but decreased in K. pneumoniae, particularly among ESBL-producers.
- Published
- 2019
5. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intra-abdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
- Author
-
Canton, R, Loza, E, Aznar, J, Castillo, FJ, Cercenado, E, Fraile-Ribot, PA, Gonzalez-Romo, F, Lopez-Hontangas, JL, Rodriguez-Lozano, J, Suarez-Barrenechea, AI, Tubau, F, Diaz-Reganon, J, Lopez-Mendoza, D, Calvo, J, Dominguez, MA, Saenz, JLP, Oliver, A, Seral, C, Garcia-Castillo, M, Romo, FG, Prieto, J, Rodriguez-Rey, A, Pascual, A, and SMART Spain Working Grp
- Subjects
antimicrobial resistance surveillance ,intra-abdominal infection ,extended-spectrum-beta-lactamases ,polycyclic compounds ,carbapenems ,bacterial infections and mycoses ,urinary tract infection - Abstract
Introduction. Continuous antimicrobial resistance surveillance is recommended by Public Health authorities. We updated data from the SMART (Study for Monitoring Antimicrobial Resistance Trends) surveillance study in Spain. Material and methods. The antimicrobial susceptibility data and extended-spectrum beta-lactamase (ESBL) production in isolates recovered from intra-abdominal (IAI) (n=1,429) and urinary tract (UTI) (n=937) infections during the 2016-2017 SMART study in 10 Spanish hospitals were analysed. Results. Escherichia coli was the most frequently microorganism isolated (48.3% and 53.7%) followed by Klebsiella spp. (11.5% and 21.9%) in IAIs and UTIs, respectively. Figures for Pseudomonas aeruginosa were 9.0% and 6.1%, being more frequently recovered from patients with nosocomial infections. Overall, 9.9% (IAI) and 14.0% (UTI) of E. coli, Klebsiella spp. and Proteus mirabilis isolates were ESBL-producers, being Klebsiella pneumoniae (34.5%) from UTI of nosocomial origin the most frequent. ESBL-producers were higher in patients >60 years in both IAIs and UTIs. As in previous years, amikacin (96.3%-100% susceptibility), ertapenem (84.2%-100%) and imipenem (70.3%-100%) were the most active antimicrobials tested among Enterobacterales species. The activity of amoxicillin-clavulanic, piperacillin-tazobactam, and ciprofloxacin susceptibility was lower, particularly among ESBL-producers. Ertapenem susceptibility (88.94%-100%) was retained in ESBL-E coli isolates that were resistant to these antimicrobials but decreased (28.64%-100%) in similar isolates of K. pneumoniae. Conclusions. Continuous antimicrobial resistance surveillance from the SMART study reveals overall maintenance of ESBL-producers in Spain, although with higher presence in isolates from UTIs than from IAIs. Moreover, ertapenem activity was high in E. coli irrespective of ESBL production but decreased in K. pneumoniae, particularly among ESBL-producers.
- Published
- 2019
6. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
- Author
-
Cantón, Rafael, Loza, Elena, Aznar Martín, Javier, Castillo, Francisco Javier, Cercenado, Emilia, Fraile-Ribot, Pablo Arturo, González-Romo, Fernando, López-Hontangas, José Luis, Rodríguez Lozano, Jesús, Suárez-Barrenechea, Ana Isabel, Tubau, Fe, Díaz-Regañón, Jazmín, López-Mendoza, Diego, MSD, and Pfizer
- Subjects
Urinary tract infection ,Intra-abdominal infection ,Carbapenems ,Antimicrobial resistance surveillance ,Infección intraabdominal ,polycyclic compounds ,Betalactamasas de espectro extendido ,bacterial infections and mycoses ,Infección urinaria ,Extended-spectrum-beta-lactamases ,Vigilancia epidemiológica de la resistencia - Abstract
[EN] Introduction: Continuous antimicrobial resistance surveillance is recommended by Public Health authorities. We up-dated data from the SMART (Study for Monitoring Antimicrobial Resistance Trends) surveillance study in Spain.-- Material and methods: The antimicrobial susceptibility data and extended-spectrum beta-lactamase (ESBL) production in isolates recovered from intra-abdominal (IAI) (n=1,429) and urinary tract (UTI) (n=937) infections during the 2016- 2017 SMART study in 10 Spanish hospitals were analysed.-- Results: Escherichia coli was the most frequently microorganism isolated (48.3% and 53.7%) followed by Klebsiella spp. (11.5% and 21.9%) in IAIs and UTIs, respectively. Figures for Pseudomonas aeruginosa were 9.0% and 6.1%, being more frequently recovered from patients with nosocomial infections. Overall, 9.9% (IAI) and 14.0% (UTI) of E. coli, Klebsiella spp. and Proteus mirabilis isolates were ESBL-producers, being Klebsiella pneumoniae (34.5%) from UTI of nosocomial origin the most frequent. ESBL-producers were higher in patients >60 years in both IAIs and UTIs. As in previous years, amikacin (96.3%-100% susceptibility), ertapenem (84.2%-100%) and imipenem (70.3%- 100%) were the most active antimicrobials tested among Enterobacterales species. The activity of amoxicillin-clavulanic, piperacillin-tazobactam, and ciprofloxacin susceptibility was lower, particularly among ESBL-producers. Ertapenem susceptibility (88.9%-100%) was retained in ESBL-E. coli isolates that were resistant to these antimicrobials but decreased (28.6%-100%) in similar isolates of K. pneumoniae.-- Conclusions: Continuous antimicrobial resistance surveillance from the SMART study reveals overall maintenance of ESBL-producers in Spain, although with higher presence in isolates from UTIs than from IAIs. Moreover, ertapenem activity was high in E. coli irrespective of ESBL production but decreased in K. pneumoniae, particularly among ESBL-producers., [ES] Introducción: Las autoridades de Salud Pública recomiendan la vigilancia continua de la resistencia a los antimicrobianos. Se actualizan los datos del estudio SMART (Study for Monitoring Antimicrobial Resistance Trends) en España.-- Material y métodos: Se analizaron los datos de sensibilidad antimicrobiana y la producción de betalactamasas de espectro extendido (BLEE) en aislamientos obtenidos en el estudio SMART de infecciones intraabdominales (IIA) (n=1.429) y del tracto urinario (ITU) (n=937) durante 2016-2017 en 10 hospitales españoles.-- Resultados: Escherichia coli fue el microorganismo más frecuente (54,5% y 57,5%, respectivamente), seguido de Klebsiella spp. (18,4% y 25,4%) en IIA y en ITU. En Pseudomonas aeruginosa estas cifras fueron 9% y 6%, siendo más frecuente en la infección nosocomial. El 9,9% (IIA) y el 14% (ITU) del to-tal de los aislados de E. coli, Klebsiella spp. y Proteus mirabilis producían BLEE, obteniéndose la tasa más alta en Klebsiella pneumoniae (34.5%) en ITU nosocomial. El mayor porcentaje de aislados con BLEE se observó en pacientes >60 años, tanto en IIA como en ITU. Como en años anteriores, amikacina (sensibilidad 96,3%-100%), ertapenem (84,2%-100%) e imipenem (70,3%-100%) fueron los antimicrobianos más activos en Enterobacterales. La sensibilidad a amoxicilina-ácido clavulánico, piperacilina-tazobactam y ciprofloxacino fue menor, en particular en los productores de BLEE. La sensibilidad a ertapenem (88,9%-100%) se mantuvo en E. coli con BLEE resistente a estos antimicrobianos, pero disminuyó (28,6%-100%) en aislados similares de K. pneumoniae.-- Conclusiones: La vigilancia continua de la resistencia a los antimicrobianos en el estudio SMART revela el mantenimiento de la frecuencia de aislados productores de BLEE en España, pero con mayor presencia en las ITUs que en las IIAs. Además, la sensibilidad a ertapenem fue alta en E. coli con independencia de la producción de BLEE, pero disminuyó en K. pneumoniae, sobre todo en los productores de BLEE., Rafael Cantón has collaborated in educational meetings sponsored by MSD and Pfizer. He has also had research grants from MSD. F. Javier Castillo has collaborated in educational meetings sponsored by MSD.
- Published
- 2019
7. Antibiotic resistance trends of ESKAPE pathogens in Kwazulu-Natal, South Africa: A five-year retrospective analysis
- Author
-
Ramsamy, Y, Essack, SY, Sartorius, B, Patel, M, and Mlisana, KP
- Subjects
0301 basic medicine ,Veterinary medicine ,medicine.drug_class ,Klebsiella pneumoniae ,030106 microbiology ,Clinical Biochemistry ,Antibiotics ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,ESKAPE pathogens ,medicine ,Antimicrobial stewardship ,Infection control ,030212 general & internal medicine ,antimicrobial resistance ,pathogen surveillance ,Original Research ,biology ,Pseudomonas aeruginosa ,business.industry ,lcsh:Public aspects of medicine ,Public Health, Environmental and Occupational Health ,lcsh:RA1-1270 ,biology.organism_classification ,Acinetobacter baumannii ,Medical Laboratory Technology ,Antimicrobial resistance surveillance ,business ,Enterococcus faecium - Abstract
Background: To combat antimicrobial resistance, the World Health Organization developed a global priority pathogen list of antibiotic-resistant bacteria for prioritisation of research and development of new, effective antibiotics. Objective: This study describes a five-year resistance trend analysis of the ESKAPE pathogens: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp., from Kwazulu-Natal, South Africa. Methods: This retrospective study used National Health Laboratory Services data on 64 502 ESKAPE organisms isolated between 2011 and 2015. Susceptibility trends were ascertained from minimum inhibitory concentrations and interpreted using Clinical and Laboratory Standards Institute guidelines. Results: S. aureus was most frequently isolated (n = 24, 495, 38%), followed by K. pneumoniae (n = 14, 282, 22%). Decreasing rates of methicillin-resistant S. aureus (28% to 18%, p < 0.001) and increasing rates of extended spectrum beta-lactamase producing K. pneumoniae (54% to 65% p < 0.001) were observed. Carbapenem resistance among K. pneumoniae and Enterobacter spp. was less than 6% during 2011–2014, but increased from 4% in 2014 to 16% in 2015 (p < 0.001) among K. pneumoniae. P. aeruginosa increased (p = 0.002), but resistance to anti-pseudomonal antimicrobials decreased from 2013 to 2015. High rates of multi-drug resistance were observed in A. baumanni (> 70%). Conclusion: This study describes the magnitude of antimicrobial resistance in KwaZulu-Natal and provides a South African perspective on antimicrobial resistance in the global priority pathogen list, signalling the need for initiation or enhancement of antimicrobial stewardship and infection control measures locally.
- Published
- 2018
8. Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
- Author
-
Wójkowska-Mach, Jadwiga, Godman, Brian, Glassman, Amanda, Kurdi, Amanj, Pilc, Andrzej, Różańska, Anna, Skoczyński, Szymon, Wałaszek, Marta, and Bochenek, Tomasz
- Subjects
0301 basic medicine ,Microbiology (medical) ,RM ,medicine.medical_specialty ,medicine.drug_class ,Dentists ,030106 microbiology ,Antibiotics ,Penicillins ,Drug resistance ,Antimicrobial resistance ,Drug Prescriptions ,beta-Lactamases ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Medical microbiology ,Antibiotic resistance ,Ambulatory care ,Physicians ,Environmental health ,Drug Resistance, Bacterial ,Humans ,Medicine ,Antimicrobial stewardship ,media_common.cataloged_instance ,lcsh:RC109-216 ,Pharmacology (medical) ,European Union ,030212 general & internal medicine ,Practice Patterns, Physicians' ,European union ,Health policy ,Practice Patterns, Dentists' ,media_common ,business.industry ,Research ,Public Health, Environmental and Occupational Health ,Drug Utilization ,Anti-Bacterial Agents ,Infectious Diseases ,Antimicrobial resistance surveillance ,Antibiotic consumption ,Poland ,business - Abstract
Background The problem of inappropriate use of antibiotics and the resulting growth in antimicrobial resistance (AMR) has implications for Poland and the world. The objective of this paper was to compare and contrast antibiotic resistance and antibiotic utilisation in Poland in recent years versus other European countries, including agreed quality indicators, alongside current AMR patterns and ongoing policies and initiatives in Poland to influence and improve antibiotic prescribing. Methods A quantitative ten-year analysis (2007–2016) of the use of antibiotics based on European Centre for Disease Prevention and Control (ECDC) data combined with a literature review on AMR rates and antimicrobial stewardship initiatives. Results The system of monitoring AMR and appropriate strategies to address AMR rates remain underdeveloped in Poland. The role of microbiological diagnostics and efforts to prevent infections is currently underestimated by physicians. Overall, Poland had one of the highest rates of total consumption of antibiotics in the analysed European countries. Total consumption of antibacterials for systemic use and relative consumption of beta-lactamase sensitive penicillins were characterized by small but statistically significant average annual increases between 2007 and 2016 (from 22.2 DIDs to 23.9 DIDs and from 0.8 to 1.3%, respectively). Conclusions The integrated activities around appropriate antibiotic prescribing in the pre- and post-graduate training of physicians and dentists seem to be particularly important, as well as changes in policies on prescribing antibiotics within ambulatory care. AMR and appropriate prescribing of antibiotics should be the focus of health policy actions in Poland.
- Published
- 2018
9. Bacterial Profile and Antibiotic Resistance among Cancer Patients with Urinary Tract Infection in a National Tertiary Cancer Hospital of Nepal
- Author
-
Srinath Satyanarayana, Nirmal Lamichhane, Kritika Rana, Xiaolin Wei, Bhola Siwakoti, Shankar Bastakoti, Kyaw Thu Soe, Gambhir Shrestha, Katrina Hann, and Rashmi Mulmi
- Subjects
medicine.medical_specialty ,medicine.drug_class ,Polymyxin ,Antibiotics ,neoplasms ,lcsh:Medicine ,Tigecycline ,Article ,Antibiotic resistance ,antimicrobial resistance surveillance ,Internal medicine ,medicine ,SORT-IT ,General Immunology and Microbiology ,business.industry ,lcsh:R ,Public Health, Environmental and Occupational Health ,operational research ,Cancer ,medicine.disease ,Multiple drug resistance ,Infectious Diseases ,Nitrofurantoin ,Amikacin ,oncology ,urinary tract infections ,business ,AWaRe ,medicine.drug - Abstract
Cancer patients are at high risk of antibiotic resistant bacterial urinary tract infections (UTIs). In this study, we assessed the bacterial profile and antibiotic resistance among cancer patients suspected of UTI in B.P. Koirala Memorial Cancer Hospital in Nepal through a cross-sectional study with routinely collected data. All cancer patients who had a recorded urine culture between July 2018–June 2019 were included in the study. Out of 308 patients who had undergone culture, 73 (24%) of samples had bacterial growth. The most common organisms isolated were E. coli (58%), Staphylococcus (11%) and Klebsiella (10%). These bacteria had undergone susceptibility testing to 27 different antibiotics in various proportions. Of the limited antibiotic testing levels, nitrofurantoin (54/66, 82%) and amikacin (30/51, 59%) were the most common. Among those tested, there were high levels of resistance to antibiotics in the “Access” and “Watch” groups of antibiotics (2019 WHO classification). In the “Reserve” group, both antibiotics showed resistance (polymyxin 15%, tigecycline 8%). Multidrug resistance was seen among 89% of the positive culture samples. This calls for urgent measures to optimize the use of antibiotics in UTI care at policy and health facility levels through stewardship to prevent further augmentation of antibiotic resistance among cancer patients.
- Published
- 2021
10. Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans
- Author
-
M. Stijntjes, N. Babu Rajendran, Evelina Tacconelli, Andreas Voss, Jesús Rodríguez-Baño, and Remco Schrijver
- Subjects
0301 basic medicine ,Microbiology (medical) ,Livestock ,Meat ,030106 microbiology ,Harmonization ,MRSA ,Antimicrobial resistance ,Representativeness heuristic ,03 medical and health sciences ,Antibiotic resistance ,Bacterial Proteins ,Salmonella ,Environmental health ,Drug Resistance, Bacterial ,Escherichia coli ,Medicine ,Animals ,Humans ,National level ,Veterinary surveillance ,Modalities ,Bacteria ,business.industry ,Campylobacter ,General Medicine ,Gene Expression Regulation, Bacterial ,Biotechnology ,Anti-Bacterial Agents ,030104 developmental biology ,Infectious Diseases ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,Antimicrobial resistance surveillance ,Population Surveillance ,Epidemiological Monitoring ,Food Microbiology ,Methicillin-resistant Staphylococcus aureus ,business ,Relevant information - Abstract
Item does not contain fulltext OBJECTIVES: In this review, we describe surveillance programmes reporting antimicrobial resistance (AMR) and resistance genes in bacterial isolates from livestock and meat and compare them with those relevant for human health. METHODS: Publications on AMR in European countries were assessed. PubMed was reviewed and AMR monitoring programmes were identified from reports retrieved by Internet searches and by contacting national authorities in EU/European Economic Area (EEA) member states. RESULTS: Three types of systems were identified: EU programmes, industry-funded supranational programmes and national surveillance systems. The mandatory EU-financed programme has led to some harmonization in national monitoring and provides relevant information on AMR and extended-spectrum beta-lactamase/AmpC- and carbapenemase-producing bacteria. At the national level, AMR surveillance systems in livestock apply heterogeneous sampling, testing and reporting modalities, resulting in results that cannot be compared. Most reports are not publicly available or are written in a local language. The industry-funded monitoring systems undertaken by the Centre Europeen d'Etudes pour la Sante Animale (CEESA) examines AMR in bacteria in food-producing animals. CONCLUSIONS: Characterization of AMR genes in livestock is applied heterogeneously among countries. Most antibiotics of human interest are included in animal surveillance, although results are difficult to compare as a result of lack of representativeness of animal samples. We suggest that EU/EEA countries provide better uniform AMR monitoring and reporting in livestock and link them better to surveillance systems in humans. Reducing the delay between data collection and publication is also important to allow prompt identification of new resistance patterns.
- Published
- 2017
11. Review of antimicrobial resistance surveillance programmes in livestock and their meat in Europe, with a focus on antimicrobial resistance patterns in humans
- Author
-
Schrijver, R, Stijntjes, M, Rodríguez-Baño, J, Tacconelli, E, Babu Rajendran, N, and Voss, A
- Subjects
Veterinary surveillance ,Livestock ,Meat ,Salmonella ,Antimicrobial resistance surveillance ,Escherichia coli ,Antimicrobial resistance ,Campylobacter ,MRSA ,Methicillin-resistant Staphylococcus aureus - Published
- 2017
12. Application of WHONET in the Antimicrobial Resistance Surveillance of Uropathogens: A First User Experience from Nepal
- Author
-
Dharm Raj Bhatta, S. Gokhale, M T Ansari, Supram Hs, A N Ghosh, A Gaur, Hare Krishna Tiwari, and J P Mathuria
- Subjects
medicine.medical_specialty ,Klebsiella pneumoniae ,medicine.drug_class ,Clinical Biochemistry ,Antibiotics ,Ceftazidime ,lcsh:Medicine ,medicine.disease_cause ,Antibiotic resistance ,antimicrobial resistance surveillance ,Ampicillin ,Internal medicine ,medicine ,biology ,business.industry ,lcsh:R ,Outbreak ,General Medicine ,biology.organism_classification ,Surgery ,Ciprofloxacin ,Staphylococcus aureus ,Original Article ,business ,urinary tract infection ,whonet ,medicine.drug - Abstract
Introduction: WHONET is a freely downloadable, Windows-based database software which is used for the management and analysis of microbiology data, with a special focus on the analysis of antimicrobial susceptibility test results. Urinary Tract Infections (UTI) are a common medical problem and they are responsible for notable morbidity among young and sexually active women. Objectives: The major objective of this study was the utilization and application of the WHONET program for the Antimicrobial Resistance (AMR) surveillance of uropathogens. Methods: A total of 3209 urine samples were collected from patients who visited Manipal Teaching Hospital with a clinical suspicion of UTI, during December 2010 to July 2011. The isolation and characterization of the isolates were done by conventional methods. Antimicrobial Susceptibility Testing (AST) was performed by Kirby Bauer’s disc diffusion method. The data entry and analysis were done by using the WHONET 5.6 software. Results: Out of the 3209 specimens, 497 bacterial isolates were obtained and they were subjected to AST. Escherichia coli (66.2%) was the commonest bacterial isolate, followed by Enterococcus species (9.3%), Staphylococcus aureus (5.0%), and Klebsiella pneumoniae (4.2%). Among the gram-negative enteric bacilli, a high prevalence of resistance was observed against ampicillin and ciprofloxacin. The gram negative nonfermenters exhibited a high degree of resistance to ceftazidime. Staphylococcus species. showed a moderately high resistance to co-trimoxazole. One isolate was Vancomycin Resistant Enterococci (VRE). Conclusion: This study, a first of its kind which was done in Nepal, was carried out by using the WHONET software to monitor, analyze and share the antimicrobial susceptibility data at various levels. This study was also aimed at building a surveillance network in Nepal, with the National Public Health Laboratory, Nepal, acting as a nodal centre. This would help in the formulation of antibiotic policies and in identifying hospital and community outbreaks at the nodal centre, as well as in sharing information with the clinicians at the local level.
- Published
- 2013
13. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012–2014 in Karachi, Pakistan
- Author
-
Saeeda Chandio, Erum Khan, Magnus Unemo, Pushpa Bhawan Mal, Kauser Jabeen, and Susanne Jacobsson
- Subjects
Male ,0301 basic medicine ,Genotyping Techniques ,Gonorrhea ,Antimicrobial resistance ,medicine.disease_cause ,0302 clinical medicine ,Prevalence ,Medicine ,Pakistan ,030212 general & internal medicine ,Child ,Molecular Epidemiology ,education.field_of_study ,N. gonorrhoeae multiantigen sequence typing (NG-MAST) ,biology ,Ceftriaxone ,Middle Aged ,Anti-Bacterial Agents ,Infectious Diseases ,Child, Preschool ,Female ,Neisseria ,Research Article ,medicine.drug ,Adult ,DNA, Bacterial ,Adolescent ,Genotype ,030106 microbiology ,Population ,Microbial Sensitivity Tests ,Microbiology ,Young Adult ,03 medical and health sciences ,Antibiotic resistance ,Extended-spectrum cephalosporins (ESCs) ,Drug Resistance, Bacterial ,Humans ,education ,Etest ,business.industry ,Infant ,biology.organism_classification ,medicine.disease ,Neisseria gonorrhoeae ,Gonorrhoea ,Treatment ,Penicillin ,Antimicrobial resistance surveillance ,business - Abstract
Background Globally, increasing antimicrobial resistance (AMR) in Neisseria gonorrhoea has led to decreased treatment options for gonorrhoea. Continuous monitoring of resistance is crucial to determine evolving resistance trends in Neisseria gonorrhoea and to suggest treatment recommendations. Quality assured gonococcal AMR data from Pakistan are mainly lacking. This study was performed to determine prevalence and trends of gonococcal AMR and molecular epidemiology of local strains during 2012–2014 in Karachi, Pakistan. Methods Gonococcal isolates (n = 100) were obtained from urogenital specimens submitted to the Aga Khan University Laboratory, Karachi, Pakistan. Antimicrobial susceptibility was determined using Etest and molecular epidemiology was assessed by N. gonorrhoeae multiantigen sequence typing (NG-MAST). Quality control was performed using N. gonorrhoeae WHO reference strains C, F, G, K, L, M, N, O, and P, and ATCC 49226. Results Susceptibility to spectinomycin, ceftriaxone and cefixime was 100 % and to azithromycin was 99 %. All isolates had low ceftriaxone MICs, i.e., ≤0.032 mg/L. Resistance to ciprofloxacin, tetracycline and penicillin G were 86 %, 51 % and 43 %, respectively. NG-MAST analysis identified 74 different sequence types (STs). Conclusions A highly diversified gonococcal population, 74 NG-MAST STs (62 novel STs) with an increased resistance to penicillin G, ciprofloxacin and tetracycline circulated in Karachi, Pakistan. Fortunately, no resistance to ceftriaxone was detected. Accordingly, ceftriaxone can continuously be recommended as the treatment of choice. However it is recommended to increase the dose of ceftriaxone from 125 mg intramuscularly to 250 mg intramuscularly due to ceftriaxone MIC creep and emerging resistance reported in the region. Furthermore, due to the high level of resistance to ciprofloxacin (86 %) it is essential to exclude ciprofloxacin from the recommended first-line therapy. It is imperative to significantly broaden the gonococcal AMR monitoring with participation from other laboratories and cities in Pakistan. Electronic supplementary material The online version of this article (doi:10.1186/s12879-016-1673-1) contains supplementary material, which is available to authorized users.
- Published
- 2016
14. Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
- Author
-
Jung Oak Kang, Seok Jeong, Hye Lim Hong, Dongeun Yong, Mi Na Kim, Kyungwon Lee, Yunsop Chong, Yeon Joon Park, Jong Hee Shin, and Jae Seok Kim
- Subjects
Carbapenem ,fluoroquinolone resistance ,Klebsiella pneumoniae ,Staphylococcus ,medicine.disease_cause ,Microbiology ,Antibiotic resistance ,Streptococcus pneumoniae ,Drug Resistance, Bacterial ,Republic of Korea ,Medicine ,Humans ,Pseudomonas Infections ,Amikacin ,Acinetobacter spp ,Cross Infection ,biology ,Acinetobacter ,business.industry ,Pseudomonas aeruginosa ,imipenem resistance ,General Medicine ,biology.organism_classification ,Anti-Bacterial Agents ,Infectious Diseases ,P. aeruginosa ,KONSAR ,Carbapenems ,Antimicrobial resistance surveillance ,Original Article ,business ,medicine.drug ,Acinetobacter Infections ,Fluoroquinolones - Abstract
Purpose The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicrobial Resistance program. Materials and Methods Susceptibility data were collected from 24 hospitals and two commercial laboratories. In the analysis, resistance did not include intermediate susceptibility. Duplicate isolates were excluded from the analysis of hospital isolates, but not from the commercial laboratory isolates. Results Among the hospital isolates, methicillin-resistant Staphylococcus aureus, penicillin G-non-susceptible Streptococcus pneumoniae based on meningitis breakpoint, and ampicillin-resistant Enterococcus faecium remained highly prevalent. The proportion of vancomycin-resistant E. faecium gradually increased to 29%. Ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae increased to 17% and 33%, respectively, and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp. and Pseudomonas aeruginosa increased to 33%, 67% and 39%, respectively. Amikacin-resistant Acinetobacter spp. increased to 48%. Imipenem-resistant Acinetobacter spp. and P. aeruginosa increased to 51% and 26%, respectively. Higher resistance rates were observed in intensive care unit (ICU) isolates than in non-ICU isolates among the isolates from hospitals. Resistance rates were higher in hospital isolates than in clinic isolates among the isolates from commercial laboratories. Conclusion Among the hospital isolates, ceftazidime-resistant K. pneumoniae and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp., and P. aeruginosa further increased. The increase in imipenem resistance was slight in P. aeruginosa, but drastic in Acinetobacter spp. The problematic antimicrobial-organism combinations were much more prevalent among ICU isolates.
- Published
- 2011
15. Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil
- Author
-
Flávia dos Santos Souza, Dália dos Prazeres Rodrigues, and Gisele Peirano
- Subjects
Microbiology (medical) ,Serotype ,Shigellosis ,lcsh:Arctic medicine. Tropical medicine ,lcsh:RC955-962 ,lcsh:QR1-502 ,Microbial Sensitivity Tests ,Drug resistance ,Biology ,medicine.disease_cause ,serovars ,lcsh:Microbiology ,Microbiology ,Antibiotic resistance ,antimicrobial resistance surveillance ,Ampicillin ,Drug Resistance, Bacterial ,Prevalence ,medicine ,Humans ,Shigella ,Serotyping ,medicine.disease ,Antimicrobial ,Cholera ,Anti-Bacterial Agents ,Brazil ,medicine.drug - Abstract
A total of 296 Shigella spp. were received from State Public Health Laboratories, during the period from 1999 to 2004, by National Reference Laboratory for Cholera and Enteric Diseases (NRLCED) - IOC/Fiocruz, Rio de Janeiro, Brazil. The frequency of Shigella spp. was: S. flexneri (52.7%), S. sonnei (44.2%), S. boydii (2.3%), and S. dysenteriae (0.6%). The most frequent S. flexneri serovars were 2a and 1b. The highest incidence rates of Shigella isolation were observed in the Southeast (39%) and Northeast (34%) regions and the lowest rate in the South (3%) of Brazil. Strains were further analyzed for antimicrobial susceptibility by disk diffusion method as part of a surveillance program on antimicrobial resistance. The highest rates of antimicrobial resistance were to trimethoprim-sulfamethozaxole (90%), tetracycline (88%), ampicillin (56%), and chloramphenicol (35%). The patterns of antimicrobial resistance among Shigella isolates pose a major difficulty in the determination of an appropriate drug for shigellosis treatment. Continuous monitoring of antimicrobial susceptibilities of Shigella spp. through a surveillance system is thus essential for effective therapy and control measures against shigellosis.
- Published
- 2006
16. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997)
- Author
-
Michael A. Pfaller, Ronald N. Jones, Patricia L. Winokur, Timothy Barrett, Helio S. Sader, and Gary V. Doern
- Subjects
Microbiology (medical) ,Urinary tract infection ,Imipenem ,Klebsiella pneumoniae ,Pseudomonas aeruginosa ,Broth microdilution ,Ceftazidime ,General Medicine ,Biology ,Acinetobacter ,biology.organism_classification ,medicine.disease_cause ,Antimicrobial ,Microbiology ,SENTRY Antimicrobial Surveillance Program ,Ciprofloxacin ,Infectious Diseases ,antimicrobial resistance surveillance ,medicine ,medicine.drug - Abstract
Objective To evaluate the antimicrobial susceptibility patterns among 469 pathogens isolated as a significant cause of urinary tract infections in 10 Latin American medical centers. Methods Consecutively collected isolates were susceptibility tested by broth microdilution methods, and selected isolates were characterized by molecular typing methods. Results Escherichia coli and Klebsiella spp. isolates revealed high rates of resistance to broad-spectrum penicillins and to fluoroquinolones. Ceftazidime MICs of ≥2 mg/L, suggesting the production of extended-spectrum β-lactamases (ESBLs), were observed in 37.7% of K. pneumoniae and 8.3% of Escherichia coli isolates. Enterobacter spp. isolates were characterized by high resistance rates to ciprofloxacin (35%) and to ceftazidime (45%), but they generally remained susceptible to cefepime (95% susceptible). Pseudomonas aeruginosa and Acinetobacter spp. were highly resistant to ciprofloxacin and ceftazidime. Imipenem was active against 80% of P. aeruginosa and 93% of Acinetobacter spp. isolates. Conclusions Our results demonstrate a high level of resistance to various classes of antimicrobial agents among isolates causing nosocomial urinary tract infections in Latin American hospitals. Clonal dissemination of ESBL-producing K. pneumoniae strains was infrequent.
- Published
- 1999
17. Increased antimicrobial consumption following reimbursement reform in Turkey
- Author
-
Salih Hosoglu, Oguz Karabay, BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, and Karabay, Oğuz
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Time Factors ,Turkey ,medicine.drug_class ,Antibiotics ,Public Policy ,Reimbursement Mechanisms ,Social insurance ,Environmental health ,Antibiotic Policy ,medicine ,Humans ,Pharmacology (medical) ,Practice Patterns, Physicians' ,Medical prescription ,Antibacterial Drug Screening Policy ,Antimicrobial Resistance Surveillance ,Health policy ,Reimbursement ,Antibacterial agent ,Pharmacology ,Consumption (economics) ,business.industry ,Commerce ,Drug Utilization ,Anti-Bacterial Agents ,Surgery ,Infectious Diseases ,Defined daily dose ,Antimicrobial Agents ,business - Abstract
WOS:000254955300033 PubMed: 18272511 Objectives: This study examined antibiotic utilization patterns in Turkey between 2001 and 2006. Methods: A comprehensive collection and analysis of Turkish antibiotic data from 2001 to 2006 was conducted. The anatomical therapeutic chemical (ATC) classification and the defined daily dose (DDD) methodology were used to calculate antibiotic consumption. Data were presented as DDD/1000 inhabitant-days, and the relation between antimicrobial consumption and governmental reimbursement policy was evaluated. Results: Total utilization of antibiotics increased from 14.62 to 31.36 DDD/1000 inhabitant-days between 2001 and 2006. The largest increase took place after the implementation of social insurance reform (SIR) in 2005, as evidenced by the DDD ratio increasing 1.87-fold after SIR went into effect. The largest increase occurred in the prescription of penicillins, from 7.13 in 2001 to 14.09 in 2006. Conclusions: In Turkey, antibiotic consumption increased markedly in recent years, in a close relationship, to a new reimbursement policy following the implementation of the SIR, which facilitated the prescription and consumption of drugs compared with the earlier SIR conditions.
- Published
- 2008
18. Access to antibiotics: a safety and equity challenge for the next decade
- Author
-
Jean Carlet and Didier Pittet
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Multidrug-resistant organisms ,medicine.drug_class ,Antibiotics ,Drug resistance ,Antimicrobial resistance ,Antibiotics – use ,Medical microbiology ,Antibiotic resistance ,Global issue ,Medicine ,Pharmacology (medical) ,Intensive care medicine ,ddc:616 ,Equity (economics) ,business.industry ,Public Health, Environmental and Occupational Health ,Biotechnology ,Multiple drug resistance ,Infectious Diseases ,Antimicrobial resistance surveillance ,Commentary ,Resource use ,business - Abstract
Bacterial resistance to antibiotics is increasing worldwide in healthcare settings and in the community. Some microbial pathogens have become resistant to multiple antibiotics, if not all presently available, thus severely compromising treatment success and contributing to enhanced morbidity, mortality, and resource use. The major driver of resistance is misuse of antibiotics in both human and non-human medicine. Both enhanced access and restricted use in many parts of the world is mandatory. There is an urgent need for an international, integrated, multi-level action to preserve antibiotics in the armamentarium of the 21st century and address the global issue of antimicrobial resistance.
- Published
- 2013
19. Can we feel it in our waters? Antimicrobials in aquaculture
- Author
-
Olasumbo Ndi, Mary D. Barton, Barton, Mary D, and Ndi, Olasumbo L
- Subjects
integumentary system ,business.industry ,alternatives to antimicrobial use ,antimicrobial use monitoring ,Australia ,food and beverages ,Drug Resistance, Microbial ,General Medicine ,Aquaculture ,Biology ,antimicrobials ,Biotechnology ,Antimicrobials in aquaculture ,acquaculture ,antimicrobial resistance surveillance ,Anti-Infective Agents ,Seafood ,seafood ,business - Abstract
Comprehensive antimicrobial use monitoring and resistance surveillance is needed for fish and seafood.
- Published
- 2012
20. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey
- Author
-
Adalet Altunsoy, İsmail Balik, Alpay Azap, Onder Ergonul, and Cenk Aypak
- Subjects
Veterinary medicine ,Imipenem ,Turkey ,Antibiotics ,Ceftazidime ,Penicillanic Acid ,antimicrobial resistance surveillance ,Klebsiella ,Medicine ,Cefepime ,Cross Infection ,biology ,Acinetobacter ,Teicoplanin ,Health Policy ,Ceftriaxone ,General Medicine ,Hospitals ,Anti-Bacterial Agents ,Piperacillin, Tazobactam Drug Combination ,Antibiotic consumption ,medicine.drug ,Research Paper ,Escherichia ,Staphylococcus aureus ,medicine.drug_class ,Drug Prescriptions ,Drug Costs ,Microbiology ,Antibiotic resistance ,Cost Savings ,Vancomycin ,Pseudomonas ,Drug Resistance, Bacterial ,Humans ,Piperacillin ,business.industry ,Meropenem ,biology.organism_classification ,Drug Utilization ,Cephalosporins ,Methicillin Resistance ,Thienamycins ,restriction policy ,business - Abstract
Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively. Results: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant E.coli and Klebsiella spp. (rho:-0.395, p:0.332 and rho:-0.627, p:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (rho:0.155, p:0.712 and rho:0.180, p:0.668, respectively for imipenem). Methicillin resistance rates of S.aureus were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred. Conclusion: NARP is effective in lowering the costs and antibiotic resistance.
- Published
- 2011
21. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae
- Author
-
Annarita Mazzariol, Luca Agostino Vitali, Giuseppe Cornaglia, and Raffaella Koncan
- Subjects
Microbiology (medical) ,Ketolides ,Genotype ,Streptococcus pyogenes ,Telithromycin ,Erythromycin ,Microbial Sensitivity Tests ,Biology ,medicine.disease_cause ,Pneumococcal Infections ,Microbiology ,azalides ,antimicrobial resistance surveillance, macrolides, azalides, group A streptococci, GAS ,antimicrobial resistance surveillance ,Streptococcal Infections ,Streptococcus pneumoniae ,Drug Resistance, Bacterial ,polycyclic compounds ,medicine ,Humans ,Pharmacology (medical) ,group A streptococci ,Ketolide ,Antibacterial agent ,Pharmacology ,Reverse Transcriptase Polymerase Chain Reaction ,Roxithromycin ,Clindamycin ,biochemical phenomena, metabolism, and nutrition ,Virology ,Anti-Bacterial Agents ,Infectious Diseases ,Italy ,GAS ,Macrolides ,medicine.drug - Abstract
Objectives: To test four 16-membered macrolides ( josamycin, spiramycin, midecamycin and rokitamycin) along with other compounds in the same class (erythromycin, clarithromycin, roxithromycin and azithromycin) plus clindamycin and telithromycin, against Streptococcus pyogenes and Streptococcus pneumoniae isolates with well-characterized resistance genotypes. Methods: Four hundred and eighty-six isolates of S. pyogenes and 375 isolates of S. pneumoniae were assayed for their macrolide susceptibilities and investigated by PCR to detect their different erythromycin resistance genes. All strains had been isolated over the period 2002–2003 from specimens of different human origin obtained in 14 different Italian centres. Results: All 16-membered macrolides showed very low MICs (MIC50s and MIC90s, � 0.06–0.5 mg/L) for the erythromycin-susceptible isolates and for those with the M phenotype, but the telithromycin MICs for the M-type isolates were at least four times higher (MIC90s, 0.5 mg/L). In S. pyogenes, the MIC50 so f 16-membered macrolides for the cMLSB isolates were � 256 mg/L, whereas that for telithromycin was 4 mg/L; the MIC50s of 16-membered macrolides and telithromycin ranged from � 0.06 to 0.5 mg/L for the iMLSB isolates with erm(A) and from 0.12 to � 256 mg/L for those with erm(B). In S. pneumoniae, the MIC50s of the 16-membered macrolides for the cMLSB isolates ranged from 0.5 to 128 mg/L, whereas for the iMLSB isolates their values ranged from � 0.06 to 4 mg/L; the MIC50s and MIC90s of telithromycin for both the cMLSB and the iMLSB isolates ranged from � 0.06 to 0.12 mg/L. Conclusions: MICs ranged for all the drugs, except telithromycin, from � 0.06 to � 256 mg/L, with 15% to 30% resistant S. pyogenes for all drugs tested except clindamycin (8%) and telithromycin (5.4%) and 10% to 40% resistant S. pneumoniae for all drugs tested except telithromycin (0.3%). In both S. pyogenes and S. pneumoniae, erythromycin resistance related to a mef gene meant that telithromycin MICs were definitely higher than in erythromycin-susceptible isolates, although telithromycin susceptibility was preserved in all cases. In S. pyogenes, the activity of both 16-membered macrolides and telithromycin against the iMLSB strains proved to be dependent on the erm gene involved, being greater against isolates with erm(A).
- Published
- 2007
22. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004
- Author
-
Hwi Jun Kim, Wee Gyo Lee, Dongeun Yong, Chang Hyun Lim, Young Uh, Ji Hyun Cho, Kyungwon Lee, and Yunsop Chong
- Subjects
Imipenem ,Klebsiella pneumoniae ,Ceftazidime ,Microbial Sensitivity Tests ,medicine.disease_cause ,Enterococcus faecalis ,Microbiology ,Drug Resistance, Multiple, Bacterial ,Streptococcus pneumoniae ,medicine ,polycyclic compounds ,Cefoxitin ,ceftazidime resistance ,Korea ,biology ,Acinetobacter ,imipenem resistance ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Hospitals ,Anti-Bacterial Agents ,Antimicrobial resistance surveillance ,Pseudomonas aeruginosa ,Original Article ,Laboratories ,Gammaproteobacteria ,medicine.drug ,Enterococcus faecium - Abstract
A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were identical to those in 2003. The most prevalent species was Staphylococcus aureus (20.2%) in hospitals, but Escherichia coli (29.7%) in the commercial laboratory. The proportions of Enterococcus faecium to all isolates of Enterococcus faecalis plus E. faecium were 47.2% in hospitals and 24.9% in the commercial laboratory. The mean resistance rates of significant antimicrobial-organism combinations in hospitals were: oxacillin-resistant S. aureus (68%), oxacillin-resistant (penicillin- nonsusceptible) Streptococcus pneumoniae (68%), vancomycin-resistant E. faecium (25%), cefotaxime-resistant E. coli (14%), ceftazidime- and cefoxitin-resistant Klebsiella pneumoniae (34% and 32%, respectively), and imipenem-resistant Acinetobacter spp. and Pseudomonas aeruginosa (17% and 24%, respectively). In conclusion, oxacillin-resistant staphylococci, expanded-spectrum cephalosporin-resistant K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa were prevalent in 2004. Increasing trends were observed for vancomycin-resistant E. faecium, cefoxitin- resistant E. coli and K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa. Certain antimicrobial- organism combinations were also prevalent among the commercial laboratory-tested strains.
- Published
- 2006
23. Increase in the Prevalence of Carbapenem-ResistantAcinetobacterIsolates and Ampicillin-Resistant Non-TyphoidalSalmonellaSpecies in Korea: A KONSAR Study Conducted in 2011
- Author
-
Gyoung Yim Ha, Hee Bong Shin, Yunsop Chong, Dongeun Yong, Wee Gyo Lee, Jihyun Cho, Seok Hoon Jeong, Kyungwon Lee, Yong Kyun Kim, and Tae Yeal Choi
- Subjects
Imipenem ,Klebsiella pneumoniae ,Staphylococcus ,Ceftazidime ,Drug resistance ,Microbiology ,Ampicillin ,polycyclic compounds ,medicine ,Pharmacology (medical) ,Cefoxitin ,Acinetobacter ,biology ,business.industry ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,biology.organism_classification ,Infectious Diseases ,KONSAR ,Amikacin ,Antimicrobial resistance surveillance ,Pseudomonas aeruginosa ,Original Article ,business ,medicine.drug - Abstract
Background Antimicrobial surveillance is important for providing an up-to-date understanding of the epidemiology of antimicrobial resistance and for creating a forum for rational drug development. In this study, we analyzed antimicrobial test data generated in 2011 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicrobial Resistance program (KONSAR). Materials and Methods Data on the results of susceptibility tests conducted in 32 hospitals and two commercial laboratories were analyzed. Data on isolates from patients admitted to an intensive care unit (ICU) and those admitted to other wards were compared. Intermediate susceptibility was not analyzed and duplicate isolates were excluded. Results Escherichia coli was the most prevalent organism identified in both the hospital and commercial laboratories. Among the hospital isolates, methicillin-resistant Staphylococcus aureus (MRSA), penicillin G-non-susceptible Streptococcus pneumoniae, and ampicillin-resistant Enterococcus faecium remained as prevalent as they were in 2009. The proportion of vancomycin-resistant E. faecium (VR-EFM) slightly decreased from 29% in 2009 to 23% in 2011. Resistance rates of Klebsiella pneumoniae to ceftazidime, cefoxitin, fluoroquinolone, and amikacin were 24%, 14%, 27%, and 8%, respectively. Resistance rates of Pseudomonas aeruginosa to fluoroquinolone, ceftazidime, imipenem, and amikacin were 33%, 20%, 22%, and 16%, respectively, whereas those of Acinetobacter spp. resistance were 71%, 66%, 64, and 51%, respectively. The prevalence of oxyimino-cephalosporin-resistant E. coli and K. pneumoniae, carbapenem-resistant Acinetobacter spp. and P. aeruginosa, MRSA, and VR-EFM among ICU isolates was higher than those among non-ICU isolates. Extended-spectrum β-lactamase-producing E. coli and K. pneumoniae, imipenem-resistant P. aeruginosa, and VR-EFM were more prevalent among isolates from commercial laboratories than those from hospitals. Resistance rates of K. pneumoniae to ceftazidime and amikacin decreased from 32% and 24% in 2005 to 24% and 8% in 2011, respectively. The resistance rate of P. aeruginosa to amikacin decreased from 22% in 2005 to 16% in 2011. The proportion of imipenem-resistant Acinetobacter spp. increased from 16% in 2005 to 64% in 2011. Conclusions The prevalence of MRSA, penicillin G-non-susceptible S. pneumoniae, and ampicillin-resistant E. faecium among clinical isolates tested in laboratories remained high. Multidrug resistance was more prevalent among isolates from ICUs. The prevalence of ceftazidime-resistant and amikacin-resistant K. pneumoniae and amikacin-resistant P. aeruginosa decreased after 2005, while the prevalence of imipenem-resistant Acinetobacter spp. increased.
- Published
- 2014
24. Increase of Ceftazidime- and Fluoroquinolone-ResistantKlebsiella pneumoniaeand Imipenem-ResistantAcinetobacterspp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007
- Author
-
Kyungwon, Lee, Mi Ae, Lee, Chae Hoon, Lee, Jongwook, Lee, Kyoung Ho, Roh, Sunjoo, Kim, Jin Ju, Kim, Eunmi, Koh, Dongeun, Yong, Yunsop, Chong, and Seong Hee, Lee
- Subjects
Methicillin-Resistant Staphylococcus aureus ,fluoroquinolone resistance ,Imipenem ,Klebsiella pneumoniae ,Ceftazidime ,MRSA ,Drug resistance ,medicine.disease_cause ,Microbiology ,Antibiotic resistance ,Vancomycin ,Drug Resistance, Bacterial ,Republic of Korea ,Escherichia coli ,medicine ,Humans ,Acinetobacter spp ,Cross Infection ,Korea ,Acinetobacter ,biology ,business.industry ,Pseudomonas aeruginosa ,imipenem resistance ,Bacterial Infections ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,biology.organism_classification ,Klebsiella Infections ,P. aeruginosa ,vancomycin resistance ,Antimicrobial resistance surveillance ,Original Article ,business ,Fluoroquinolones ,medicine.drug ,Enterococcus faecium - Abstract
Purpose: Antimicrobial resistance monitoring could be a useful source of information for treating and controlling nosocomial infections. We analyzed antimicrobial resistance data generated by Korean Hospitals and by a commercial laboratory in 2005 and 2007. Materials and Methods: Susceptibility data for 2005 and 2007 were collected from 37 and 41 hospitals, respectively, and from one commercial laboratory. Intermediate susceptibility was not included in the calculation of resistance rates. Results: Methicillin-resistant Staphylococcus aureus (MRSA) (64%), third-generation cephalosporin-resistant Klebsiella pneumoniae (29%), fluoroquinolone-resistant Escherichia coli (27%), Pseudomonas aeruginosa (33%), and Acinetobacter spp. (48%), and amikacin-resistant P. aeruginosa (19%) and Acinetobacter spp. (37%) were prevalent in hospitals in 2007. A gradual increase of vancomycin-resistant Enterococcus faecium and imipenem-resistant Acinetobacter spp. was observed. Higher incidences of thirdgeneration cephalosporin-resistant E. coli and K. pneumoniae and imipenemresistant P. aeruginosa were found in the commercial laboratory than in the hospitals. Conclusion: Methicillin-resistant S. aureus, third-generation cephalosporin-resistant K. pneumoniae, and fluoroquinolone-resistant E. coli, P. aeruginosa and Acinetobacter spp. remain prevalent in Korea, while the incidence of vancomycin-resistant E. faecium and imipenem-resistant Acinetobacter spp. has increased gradually. The higher prevalences of third-generation cephalosporinresistant E. coli and K. pneumoniae, and imipenem-resistant P. aeruginosa in the commercial laboratory are a new concern.
- Published
- 2010
25. Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
- Author
-
Hwan Sub Lim, Kyungwon Lee, Seok Hoon Jeong, Jong Hee Shin, Gyoung Yim Ha, Ki Hyung Park, Dongeun Yong, and Yunsop Chong
- Subjects
fluoroquinolone resistance ,Imipenem ,Klebsiella pneumoniae ,Enterococcus faecium ,Microbial Sensitivity Tests ,Drug resistance ,Microbiology ,Antibiotic resistance ,Vancomycin ,Drug Resistance, Bacterial ,Humans ,Medicine ,Amikacin ,Gram-Positive Bacterial Infections ,Korea ,Acinetobacter ,biology ,business.industry ,imipenem resistance ,Vancomycin Resistance ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,Antimicrobial ,biology.organism_classification ,Anti-Bacterial Agents ,Klebsiella Infections ,Antimicrobial resistance surveillance ,Population Surveillance ,Original Article ,Gram-Negative Bacterial Infections ,business ,Gammaproteobacteria ,Acinetobacter Infections ,Fluoroquinolones ,medicine.drug - Abstract
Monitoring temporal trends of antimicrobial resistance can provide useful information for the empirical selection of antimicrobial agents to treat infected patients and for the control of nosocomial infections. In this study, we analyzed antimicrobial resistance of clinically relevant bacteria in 2003 at Korean hospitals and at a commercial laboratory. The following organism-antimicrobial agent resistance combinations were very prevalent: oxacillin-resistant Staphylococcus aureus (68%), expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae (25%), and fluoroquinolone-resistant Escherichia coli (33%), Acinetobacter spp. (58%), and Pseudomonas aeruginosa (40%). Moreover, gradual increases in vancomycin-resistant Enterococcus faecium (20%), cefoxitin-resistant E. coli (10%) and K. pneumoniae (23%), and imipenem-resistant P. aeruginosa (20%) and Acinetobacter spp. (13%) were also observed. The resistance rates of Acinetobacter spp. to most antimicrobial agents at hospitals and at the commercial laboratory were similar. Among the Acinetobacter spp. isolated at a tertiary-care hospital, 46.2% were multidrug-resistant to 9-12 of 13 antimicrobial agents, and 18.3% were panresistant. The exclusion of duplicate isolates at a tertiary-care hospital significantly lowered the proportion of oxacillin-resistant S. aureus, vancomycin-resistant E. faecium, and fluoroquinolone-resistant E. coli.
- Published
- 2006
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.